Literature DB >> 11953016

Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC.

Y Suen1, S M Lee, F Aono, S Hou, M Loudovaris, G Ofstein, J G Bender.   

Abstract

BACKGROUND: DC generated from monocytes have been used for vaccines. We have developed a monocyte enrichment procedure by depleting T and B cells with anti-CD2 and anti-CD19 Abs using the automated Isolex 300i magnetic cell selector for clinical-scale DC generation in gas permeable SteriCell culture bags. We have also compared DC function, yield and purity of DC generated from adherent monocytes using culture bags in a closed system, with DC generated in conventional tissue culture flasks.
METHODS: Monocytes were enriched from normal donor apheresis products using CD2/19 depletion with experimental software on the Isolex 300i (ISO), adherence (AD) to SteriCell bags and to T175 flasks and then cultured for 7 days in serum-free X-VIVO 15 media with GM-CSF and IL-4. Phenotype and dextran uptake were analyzed by flow cytometry and allogeneic MLR was also evaluated.
RESULTS: ISO-DC and AD-DC from SteriCell bags showed similar viability. Higher purity of ISO-DC than AD-DC was measured by forward- and side-scatter flow cytometry. Similar expression of CD1a, CD80, CD86 and CD83 were observed in both ISO-DC and AD-DC. Similar dextran uptake and allo MLR were also observed. DISCUSSION: These data indicated that functional DC were generated in gas permeable SteriCell culture bags from both ISO- and AD-monocytes in a closed system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11953016     DOI: 10.1080/146532401753277184

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  4 in total

1.  Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy.

Authors:  Timo Buhl; Tobias J Legler; Albert Rosenberger; Anke Schardt; Michael P Schön; Holger A Haenssle
Journal:  Cancer Immunol Immunother       Date:  2012-04-22       Impact factor: 6.968

2.  Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.

Authors:  Yasuto Akiyama; Ryuji Tanosaki; Naoki Inoue; Makiko Shimada; Yukie Hotate; Akifumi Yamamoto; Naoya Yamazaki; Ichiro Kawashima; Ikuei Nukaya; Kazutoh Takesako; Kouji Maruyama; Yoichi Takaue; Ken Yamaguchi
Journal:  J Transl Med       Date:  2005-01-28       Impact factor: 5.531

3.  Closing the system: production of viral antigen-presenting dendritic cells eliciting specific CD8+ T cell activation in fluorinated ethylene propylene cell culture bags.

Authors:  Jean-Philippe Bastien; Natalie Fekete; Ariane V Beland; Marie-Paule Lachambre; Veronique Laforte; David Juncker; Vibhuti Dave; Denis-Claude Roy; Corinne A Hoesli
Journal:  J Transl Med       Date:  2020-10-09       Impact factor: 5.531

4.  Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines.

Authors:  Alexander Michael Dohnal; Sebastian Graffi; Volker Witt; Christina Eichstill; Dagmar Wagner; Sidrah Ul-Haq; Doris Wimmer; Thomas Felzmann
Journal:  J Cell Mol Med       Date:  2008-03-17       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.